TY - JOUR
T1 - Insights into Metabolic Reprogramming in Tumor Evolution and Therapy
AU - Chiu, Ching Feng
AU - Guerrero, Jonathan Jaime G.
AU - Regalado, Ric Ryan H.
AU - Zamora, Ma Joy B.
AU - Zhou, Jiayan
AU - Notarte, Kin Israel
AU - Lu, Yu Wei
AU - Encarnacion, Paolo C.
AU - Carles, Cidne Danielle D.
AU - Octavo, Edrian M.
AU - Limbaroc, Dan Christopher I.
AU - Saengboonmee, Charupong
AU - Huang, Shih Yi
N1 - Publisher Copyright:
© 2024 by the authors.
PY - 2024/10
Y1 - 2024/10
N2 - Background: Cancer remains a global health challenge, characterized not just by uncontrolled cell proliferation but also by the complex metabolic reprogramming that underlies its development and progression. Objectives: This review delves into the intricate relationship between cancer and its metabolic alterations, drawing an innovative comparison with the cosmological concepts of dark matter and dark energy to highlight the pivotal yet often overlooked role of metabolic reprogramming in tumor evolution. Methods: It scrutinizes the Warburg effect and other metabolic adaptations, such as shifts in lipid synthesis, amino acid turnover, and mitochondrial function, driven by mutations in key regulatory genes. Results: This review emphasizes the significance of targeting these metabolic pathways for therapeutic intervention, outlining the potential to disrupt cancer’s energy supply and signaling mechanisms. It calls for an interdisciplinary research approach to fully understand and exploit the intricacies of cancer metabolism, pointing toward metabolic reprogramming as a promising frontier for developing more effective cancer treatments. Conclusion: By equating cancer’s metabolic complexity with the enigmatic nature of dark matter and energy, this review underscores the critical need for innovative strategies in oncology, highlighting the importance of unveiling and targeting the “dark energy” within cancer cells to revolutionize future therapy and research.
AB - Background: Cancer remains a global health challenge, characterized not just by uncontrolled cell proliferation but also by the complex metabolic reprogramming that underlies its development and progression. Objectives: This review delves into the intricate relationship between cancer and its metabolic alterations, drawing an innovative comparison with the cosmological concepts of dark matter and dark energy to highlight the pivotal yet often overlooked role of metabolic reprogramming in tumor evolution. Methods: It scrutinizes the Warburg effect and other metabolic adaptations, such as shifts in lipid synthesis, amino acid turnover, and mitochondrial function, driven by mutations in key regulatory genes. Results: This review emphasizes the significance of targeting these metabolic pathways for therapeutic intervention, outlining the potential to disrupt cancer’s energy supply and signaling mechanisms. It calls for an interdisciplinary research approach to fully understand and exploit the intricacies of cancer metabolism, pointing toward metabolic reprogramming as a promising frontier for developing more effective cancer treatments. Conclusion: By equating cancer’s metabolic complexity with the enigmatic nature of dark matter and energy, this review underscores the critical need for innovative strategies in oncology, highlighting the importance of unveiling and targeting the “dark energy” within cancer cells to revolutionize future therapy and research.
KW - cancer
KW - metabolic reprogramming
KW - Warburg effect
KW - cancer
KW - metabolic reprogramming
KW - Warburg effect
UR - http://www.scopus.com/inward/record.url?scp=85207661329&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85207661329&partnerID=8YFLogxK
U2 - 10.3390/cancers16203513
DO - 10.3390/cancers16203513
M3 - Review article
AN - SCOPUS:85207661329
SN - 2072-6694
VL - 16
JO - Cancers
JF - Cancers
IS - 20
M1 - 3513
ER -